Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
3
Number of overlapping holdings
33.3%
% of PSIL's 28 holdings also in IBRN
7.9%
% of IBRN's 52 holdings also in PSIL
Overlap by Weight
Sector Drift (PSIL minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PSIL |
Weight in IBRN |
Overlap | |
---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 4.6% | 4.7% | 4.6% | |
INTRA-CELLULAR THERAPIES INC | 4.5% | 4.8% | 4.5% | |
ALKERMES PLC | 6.3% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
PSIL Overweight Relative to IBRN
ATAI LIFE SCIENCES N.V. | 6.4% | |
INCANNEX HEALTHCARE INC. | 5.2% | |
SAGE THERAPEUTICS INC | 4.3% | |
ALKERMES PLC | 2.5% | |
RELMADA THERAPEUTICS INC | 1.3% | |
NUMINUS WELLNESS INC | 1.2% | |
NEURONETICS, INC. | 0.3% | |
NEUROCRINE BIOSCIENCES INC | -0.1% | |
IDORSIA LTD. | -0.2% | |
ELIEM THERAPEUTICS, INC. | -0.2% |
PSIL Underweight Relative to IBRN
SK BIOPHARMACEUTICALS CO., LTD. | -4.6% | |
ARGENX SE ADR | -4.5% | |
SUPERNUS PHARMACEUTICALS INC | -4.3% | |
ACADIA PHARMACEUTICALS INC | -4.2% | |
CATALYST PHARMACEUTICAL PART | -4.2% | |
SAREPTA THERAPEUTICS INC | -4.1% | |
BIOGEN IDEC INC | -4.0% | |
SCHOLAR ROCK HOLDING CORP. | -3.9% | |
PTC THERAPEUTICS INC | -3.9% | |
INTEGRA LIFESCIENCES HOLDING | -3.3% |